0000947871-24-000616.txt : 20240715
0000947871-24-000616.hdr.sgml : 20240715
20240715194847
ACCESSION NUMBER: 0000947871-24-000616
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240715
DATE AS OF CHANGE: 20240715
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001831363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39926
FILM NUMBER: 241118387
BUSINESS ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-525-5535 EXT.101
MAIL ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC
CENTRAL INDEX KEY: 0001055951
ORGANIZATION NAME:
IRS NUMBER: 133976876
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
144
1
primary_doc.xml
144
0001055951
XXXXXXXX
LIVE
0001831363
Terns Pharmaceuticals, Inc.
001-39926
1065 East Hillsdale Blvd., Suite 100
Foster City
CA
94404
650-525-5535
OrbiMed Genesis Master Fund, LP
Director
Shareholder
Common Stock
TD Cowen
599 Lexington Avenue
New York
NY
10022
152400
1418844.00
64677145
07/15/2024
Nasdaq
Common Stock
08/12/2022
Private Placement
Issuer
N
152400
08/12/2022
Cash
Y
OrbiMed Genesis GP LLC is the general partner of OrbiMed Genesis Master Fund, LP. OrbiMed Advisors LLC is the managing member of OrbiMed Genesis GP LLC.
07/15/2024
/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Genesis Master Fund, LP